European Code against Cancer, 4th Edition: Tobacco and cancer

Cancer Epidemiology

Volumn 39, Issue , 2015, Pages S20-S33

  Leon, Maria E ^a   Peruga, Armando ^b   McNeill, Ann ^c   Kralikova, Eva ^d   Guha, Neela ^a   Minozzi, Silvia ^e   Espina, Carolina ^a   Schüz, Joachim ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CHARLES UNIVERSITY   (Czech Republic)

^e CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Cessation; Europe; Lung cancer; Nicotine; Primary prevention; Second hand smoke; Smoke free home; Smokeless; Smoking; Snus

Indexed keywords

ALDEHYDE; AROMATIC AMINE; CARCINOGEN; NICOTINE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; VOLATILE ORGANIC COMPOUND;

ARTICLE; BEHAVIOR THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; ENVIRONMENTAL EXPOSURE; EUROPEAN UNION; HUMAN; LUNG CANCER; MEDICATION THERAPY MANAGEMENT; NEOPLASM; PASSIVE SMOKING; PRIORITY JOURNAL; RISK REDUCTION; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO DEPENDENCE; TOBACCO USE; WORKPLACE; ADULT; ADVERSE EFFECTS; NEOPLASMS; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS;

ADULT; CARCINOGENS; EUROPEAN UNION; GUIDELINES AS TOPIC; HUMANS; NEOPLASMS; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO;

EID: 84977461299     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.06.001     Document Type: Article

References (95)

1. [1] European Commission, Smoking and the Environment: Actions and Attitudes. Special Eurobarometer. 2003, European Commission, Directorate-General Health and Consumers. Special Eurobarometer 183/Wave 58.2.
2. [2] European Commission, Attitudes of Europeans Towards Tobacco. Report. Special Eurobarometer 385. 2012, European Commission, Directorate-General Health and Consumers. Special Eurobarometer.
3. [3] World Health Organization, Systematic Review of the Link Between Tobacco and Poverty – 2014 update. 2014, World Health Organization, Geneva.
4. [4] Gallus, S., Lugo, A., La Vecchia, C., et al. Pricing Policies And Control of Tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries. Eur. J. Cancer Prev. 23 (2014), 177–185.
5. [5] Gallus, S., Lugo, A., La Vecchia, C., Pricing Policies and Control of Tobacco in Europe (PPACTE) project: smoking prevalence and consumption in 18 European countries. Final report. PPACTE Consortium, Dublin, 2011.
6. [6] Gallus, S., Lugo, A., Ghislandi, S., et al. Roll-your-own cigarettes in Europe: use, weight and implications for fiscal policies. Eur. J. Cancer Prev. 23 (2014), 186–192.
7. [7] Gilmore, A.B., Tavakoly, B., Hiscock, R., et al. Smoking patterns in Great Britain: the rise of cheap cigarette brands and roll your own (RYO) tobacco. J. Public Health (Oxf.) 37:1 (2015), 78–88.
8. [8] Currie, L., Towsend, J., Leon Roux, M., et al. Policy recommendations for tobacco taxation in the European Union integrated research findings from the PPACTE project. The PPACTE Consortium, Dublin, 2012, 1–145.
9. [9] Jawad, M., Wilson, A., Lee, J.T., et al. Prevalence and predictors of water pipe and cigarette smoking among secondary school students in London. Nicotine Tob. Res. 15 (2013), 2069–2075.
10. [10] Maziak, W., Taleb, Z.B., Bahelah, R., et al. The global epidemiology of waterpipe smoking. Tob. Control 24 (2015), i3–i12.
11. [11] European Council, Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/CE. Off. J. Eur. Union L127 (2014), 1–37.
12. [12] Pearson, N., Croucher, R., Marcenes, W., et al. Prevalence of oral lesions among a sample of Bangladeshi medical users aged 40 years and over living in Tower Hamlets, UK. Int. Dent. J. 51 (2001), 30–34.
13. [13] Prabhu, N.T., Warnakulasuriya, K., Gelbier, S., et al. Betel quid chewing among Bangladeshi adolescents living in east London. Int. J. Paediatr. Dent. 11 (2001), 18–24.
14. [14] Warnakulasuriya, S., Areca nut use following migration and its consequences. Addict. Biol. 7 (2002), 127–132.
15. [15] Croucher, R., Dahiya, M., Gowda, K.K., Contents and price of vendor assembled paan quid with tobacco in five London localities: a cross-sectional study. Tob. Control 22 (2013), 141–143.
16. [16] International Agency for Research on Cancer, Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum., 2012, 1–538.
17. [17] European Commission, Report on the implementation of the Council Recommendation of 30 November 2009 on Smoke-free Environments (2009/C 296/02)., 2013, European Commission, Brussels.
18. [18] European Commission, Smoke-free environments. Overview and Country Specific Restrictions, 2015, European Commission http://ec.europa.eu/health/tobacco/smoke-free_environments/index_en.htm.
19. [19] World Health Organization, WHO report on the global tobacco epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. 2013, World Health Organization, Geneva.
20. [20] Pisinger, C., Hammer-Helmich, L., Andreasen, A.H., et al. Social disparities in children's exposure to second hand smoke at home: a repeated cross-sectional survey. Environ. Health, 11, 2012, 65.
21. [21] Heck, J.E., Stucker, I., Allwright, S., et al. Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic. Eur. Respir. J. 35 (2010), 969–979.
22. [22] Ferketich, A.K., Lugo, A., La, V.C., et al. Relation between national-level tobacco control policies and individual-level voluntary home smoking bans in Europe. Tob. Control, 2014.
23. [23] GTSS Collaborating Group, Global Tobacco Surveillance System (GTSS): purpose, production, and potential. J. Sch. Health 75 (2005), 15–24.
24. [24] World Health Organization, WHO Framework Convention on Tobacco Control. 2003, World Health Organization, Geneva.
25. [25] International Agency for Research on Cancer, Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum. 83 (2004), 1–1438.
26. [26] International Agency for Research on Cancer, Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 89 (2007), 1–592.
27. [27] Hecht, S.S., Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3 (2003), 733–744.
28. [28] Stark, M.J., Rohde, K., Maher, J.E., et al. The impact of clean indoor air exemptions and preemption policies on the prevalence of a tobacco-specific lung carcinogen among nonsmoking bar and restaurant workers. Am. J. Public Health 97 (2007), 1457–1463.
29. [29] Thomas, J.L., Guo, H., Carmella, S.G., et al. Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes. Cancer Epidemiol. Biomarkers Prev. 20 (2011), 1213–1221.
30. [30] Pirkle, J.L., Bernert, J.T., Caudill, S.P., et al. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988–2002. Environ. Health Perspect. 114 (2006), 853–858.
31. [31] Hecht, S.S., Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol. 21 (2008), 160–171.
32. [32] Suwan-ampai, P., Navas-Acien, A., Strickland, P.T., et al. Involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999 to 2002. Cancer Epidemiol. Biomarkers Prev. 18 (2009), 884–893.
33. [33] Cogliano, V.J., Baan, R., Straif, K., et al. Preventable exposures associated with human cancers. J. Natl. Cancer Inst. 103 (2011), 1827–1839.
34. [34] International Agency for Research on Cancer, Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. IARC Working Group. Lyon, 23–30 October 1984. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 37 (1985), 1–268.
35. [35] International Agency for Research on Cancer, Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 85 (2004), 1–334.
36. [36] Boffetta, P., Hecht, S., Gray, N., et al. Smokeless tobacco and cancer. Lancet Oncol. 9 (2008), 667–675.
37. [37] Ferlay, J., Soerjomataram, I., Ervik, M., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. 2013, International Agency for Research on Cancer.
38. [38] Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer 49 (2013), 1374–1403.
39. [39] Yuan, J.M., Koh, W.P., Murphy, S.E., et al. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res. 69 (2009), 2990–2995.
40. [40] Chang, J.S., Straif, K., Guha, N., The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C. Mutagenesis 27 (2012), 275–286.
41. [41] Lagergren, J., Bergstrom, R., Lindgren, A., et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int. J. Cancer 85 (2000), 340–346.
42. [42] Doll, R., Peto, R., Boreham, J., et al. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ, 328, 2004, 1519.
43. [43] Doll, R., Peto, R., Wheatley, K., et al. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 309 (1994), 901–911.
44. [44] International Agency for Research on Cancer, Reversal of Risk After Quitting Smoking, vol. 11, 2007, IARC Handbooks of Cancer Prevention, Tobacco Control, Lyon, France.
45. [45] Agudo, A., Bonet, C., Travier, N., et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J. Clin. Oncol. 30 (2012), 4550–4557.
46. [46] Thun, M.J., Lopez, A.D., Hartge, P., Smoking-related mortality in the United States. N. Engl. J. Med., 368, 2013, 1753.
47. [47] Jha, P., Peto, R., Global effects of smoking, of quitting, and of taxing tobacco. N. Engl. J. Med. 370 (2014), 60–68.
48. [48] Brown, J., West, R., Smoking prevalence in England is below 20% for the first time in 80 years. BMJ, 348, 2014, g1378.
49. [49] Lortet-Tieulent, J., Soerjomataram, I., Ferlay, J., et al. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer 84 (2014), 13–22.
50. [50] Parkin, D.M., Tobacco-attributable cancer burden in the UK in 2010. Br. J. Cancer 105:Suppl. 2 (2011), S6–S13.
51. [51] World Health, Organization, Oberg, M., Jaakkola, M.S., Pruss-Ustun, A., Peruga, A., Woodward, A., (eds.) Global Estimate of the Burden of Disease From Second-Hand Smoke, 2010, World Health Organization, Geneva.
52. [52] National Cancer Institute and Centers for Disease Control and Prevention, Smokeless Tobacco and Public Health: A Global Perspective. 2014, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health National Cancer Institute. NIH Publication No. 14-7983, Bethesda, MD.
53. [53] Brennan, P., Crispo, A., Zaridze, D., et al. High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am. J. Epidemiol. 164 (2006), 1233–1241.
54. [54] Jha, P., Ramasundarahettige, C., Landsman, V., et al. 21st-century hazards of smoking and benefits of cessation in the United States. N. Engl. J. Med. 368 (2013), 341–350.
55. [55] Pirie, K., Peto, R., Reeves, G.K., et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381 (2013), 133–141.
56. [56] Peto, R., Darby, S., Deo, H., et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321 (2000), 323–329.
57. [57] Stead, L.F., Lancaster, T., Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst. Rev., 12, 2012, CD009670.
58. [58] Moore, D., Aveyard, P., Connock, M., et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ, 338, 2009, b1024.
59. [59] Hughes, J.R., Stead, L.F., Lancaster, T., Antidepressants for smoking cessation. Cochrane Database Syst. Rev., 2007, CD000031.
60. [60] Hughes, J.R., Stead, L.F., Hartmann-Boyce, J., et al. Antidepressants for smoking cessation. Cochrane Database Syst. Rev., 1, 2014, CD000031.
61. [61] Cahill, K., Stead, L.F., Lancaster, T., Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst. Rev., 4, 2012, CD006103.
62. [62] Tutka, P., Zatonski, W., Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy. Pharmacol. Rep. 58 (2006), 777–798.
63. [63] West, R., Zatonski, W., Cedzynska, M., et al. Placebo-controlled trial of cytisine for smoking cessation. N. Engl. J. Med. 365 (2011), 1193–1200.
64. [64] Walker, N., Howe, C., Glover, M., et al. Cytisine versus nicotine for smoking cessation. N. Engl. J. Med. 371 (2014), 2353–2362.
65. [65] Cahill, K., Stevens, S., Perera, R., et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst. Rev., 5, 2013, CD009329.
66. [66] Stead, L.F., Bergson, G., Lancaster, T., Physician advice for smoking cessation. Cochrane Database Syst. Rev., 2008, CD000165.
67. [67] Lancaster, T., Stead, L.F., Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev., 2005, CD001292.
68. [68] Stead, L.F., Lancaster, T., Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst. Rev., 2005, CD001007.
69. [69] Brandon, T.H., Collins, B.N., Juliano, L.M., et al. Preventing relapse among former smokers: a comparison of minimal interventions through telephone and mail. J. Consult. Clin. Psychol. 68 (2000), 103–113.
70. [70] Stead, L.F., Perera, R., Lancaster, T., Telephone counselling for smoking cessation. Cochrane Database Syst. Rev., 2006, CD002850.
71. [71] Stead, L.F., Hartmann-Boyce, J., Perera, R., et al. Telephone counselling for smoking cessation. Cochrane Database Syst. Rev., 8, 2013, CD002850.
72. [72] International Agency for Research on Cancer, Evaluating the effectiveness of smoke-free policies, vol. 13, 2009, IARC Handbooks of Cancer Prevention, Tobacco Control, Lyon, France.
73. [73] Matt, G.E., Quintana, P.J., Hovell, M.F., et al. Households contaminated by environmental tobacco smoke: sources of infant exposures. Tob. Control 13 (2004), 29–37.
74. [74] Pierce, J.P., Gilpin, E.A., Emery, S.L., et al. Has the California tobacco control program reduced smoking. JAMA 280 (1998), 893–899.
75. [75] Pizacani, B.A., Martin, D.P., Stark, M.J., et al. A prospective study of household smoking bans and subsequent cessation related behaviour: the role of stage of change. Tob. Control 13 (2004), 23–28.
76. [76] Shields, M., The journey to quitting smoking. Health Rep. 16 (2005), 19–36.
77. [77] Shields, M., Smoking bans: influence on smoking prevalence. Health Rep. 18 (2007), 9–24.
78. [78] Borland, R., Yong, H.H., Cummings, K.M., et al. Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob. Control 15:Suppl. 3 (2006), iii42–iii50.
79. [79] Messer, K., Mills, A.L., White, M.M., et al. The effect of smoke-free homes on smoking behavior in the U.S. Am. J. Prev. Med. 35 (2008), 210–216.
80. [80] Hyland, A., Higbee, C., Travers, M.J., et al. Smoke-free homes and smoking cessation and relapse in a longitudinal population of adults. Nicotine Tob. Res. 11 (2009), 614–618.
81. [81] Jarvis, M.J., Sims, M., Gilmore, A., et al. Impact of smoke-free legislation on children's exposure to secondhand smoke: cotinine data from the Health Survey for England. Tob. Control 21 (2012), 18–23.
82. [82] Sims, M., Mindell, J.S., Jarvis, M.J., et al. Did smokefree legislation in England reduce exposure to secondhand smoke among nonsmoking adults? Cotinine analysis from the Health Survey for England. Environ. Health Perspect. 120 (2012), 425–430.
83. [83] Fong, G.T., Craig, L.V., Guignard, R., et al. Evaluation of the smoking ban in public places in France one year and five years after its implementation: findings from the ITC France survey. Bull. Epidemiol. Hebd. (Paris) 20 (2013), 217–223.
84. [84] Juster, H.R., Loomis, B.R., Hinman, T.M., et al. Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am. J. Public Health 97 (2007), 2035–2039.
85. [85] Cesaroni, G., Forastiere, F., Agabiti, N., et al. Effect of the Italian smoking ban on population rates of acute coronary events. Circulation 117 (2008), 1183–1188.
86. [86] Pell, J.P., Haw, S., Cobbe, S., et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N. Engl. J. Med. 359 (2008), 482–491.
87. [87] Callinan, J.E., Clarke, A., Doherty, K., et al. Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst. Rev., 2010, CD005992.
88. [88] Sims, M., Maxwell, R., Bauld, L., et al. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ, 340, 2010, c2161.
89. [89] Liu, A., Guzman, C.M., Capewell, S., et al. Reduction in myocardial infarction admissions in Liverpool after the smoking ban: potential socioeconomic implications for policymaking. BMJ Open, 3, 2013, e003307.
90. [90] Mackay, D.F., Haw, S., Newby, D.E., et al. Impact of Scotland's comprehensive, smoke-free legislation on stroke. PLOS ONE, 8, 2013, e62597.
91. [91] Mackay, D.F., Irfan, M.O., Haw, S., et al. Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart 96 (2010), 1525–1530.
92. [92] Hymowitz, N., Cummings, K.M., Hyland, A., et al. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob. Control 6:Suppl. 2 (1997), S57–S62.
93. [93] O'Loughlin, J., Paradis, G., Renaud, L., et al. One-year predictors of smoking initiation and of continued smoking among elementary schoolchildren in multiethnic, low-income, inner-city neighbourhoods. Tob. Control 7 (1998), 268–275.
94. [94] Tyas, S.L., Pederson, L.L., Psychosocial factors related to adolescent smoking: a critical review of the literature. Tob. Control 7 (1998), 409–420.
95. [95] National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, Centers for Disease Control and Prevention, Department of Health and Human Services, The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General., 2014.